Amphastar Pharmaceuticals
AMPH
#5766
Rank
ยฃ0.96 B
Marketcap
ยฃ22.61
Share price
2.10%
Change (1 day)
14.76%
Change (1 year)

EPS for Amphastar Pharmaceuticals (AMPH)

EPS in 2026 (TTM): ยฃ1.30

According to Amphastar Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ1.32. In 2025 the company made an earnings per share (EPS) of ยฃ1.60 a decrease over its 2024 EPS that were of ยฃ2.50.

EPS history for Amphastar Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ1.30-18.48%
2025ยฃ1.60-36.17%
2024ยฃ2.5015.85%
2023ยฃ2.1651.87%
2022ยฃ1.4243.85%
2021ยฃ0.993521.88%
2020ยฃ0.02731-96.55%
2019ยฃ0.79-900%
2018-ยฃ0.09892-238.6%
2017ยฃ0.07137-60.92%
2016ยฃ0.18
2014-ยฃ0.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tonix Pharmaceuticals
TNXP
-ยฃ9.85-843.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-ยฃ3.96-398.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
-ยฃ1.78-234.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-ยฃ2.94-322.41%๐Ÿ‡บ๐Ÿ‡ธ USA